Are you a member yet? Membership is open to all and is the first step towards accreditation.
29 June 2022
“CBT remains the treatment of choice for adults with depression”
The British Association for Behavioural and Cognitive Psychotherapies, the lead organisation for CBT in the UK and Ireland, welcome revisions to the NICE guidelines on depression in adults (released 29th June 2022). BABCP very strongly welcome the recommendation that cognitive and behavioural therapies are the treatment of choice for less severe and more severe depression.
BABCP President Dr Andrew Beck said
“These guidelines offer a real opportunity for NHS mental health services to listen to what patients need and want, and to collaborate with them to decide what treatment and care they need. The guidelines also highlight the amazing value of psychological well-being practitioners at the front line of mental health services, working alongside specialist CBT therapists, and other staff in multidisciplinary teams
Guided self-help with Psychological Wellbeing Practitioners is the treatment of choice for adults with less severe depression.
The NICE guidelines recognise the importance of the offering people the least intrusive treatment first, with the option to try more intensive treatment if needed. Depression is a common mental health problem, that affects at least 3 in a hundred people at any one time, with serious and sometimes fatal consequences. Offering evidence-based treatment quickly is critical, will help more people recover, and makes best use of NHS resources.
NICE considered detailed feedback from BABCP members. In response, they adapted the guidance in several crucial ways. In particular, the voices of Psychological Wellbeing Practitioners (PWPs) were listened to and the value of their role is recognised and even strengthened in this guidance.
Cognitive and behavioural therapies are also the treatments of choice for more severe depression, in combination with anti-depressant medication if this is acceptable to the individual patient.
The guidelines also recognise that patient’s preferences about individual or group therapy, and medication are central in making decisions about treatment.
Other important changes following our feedback, include:
BABCP have concerns about some areas of the guidance
We look forward to reading and commenting on the Implementation Guide which NICE will be publishing in due course, and further reviews of the evidence for treatment for this important patient group.
For further comment please contact email@example.com